AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Sugwin-VG 2mg/500mg/0.2mg Tablet

Prescription Icon
Prescription Required

Marketer

MaxQure Labs

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Sugwin-VG 2mg/500mg/0.2mg Tablet

Diabex-Trio 2mg/500mg/0.2mg tablets are classified as antidiabetic medications. This combination therapy is indicated for managing type 2 diabetes in adults, helping regulate blood glucose. Diabex-Trio should be administered with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your glycemic response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to hyperglycemia, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Prompt recognition and treatment are essential; maintain regular meals and carry a readily available fast-acting glucose source. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur in some patients. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation prior to use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to assess blood cell counts and liver function.

Primary Ingredients of Sugwin-VG 2mg/500mg/0.2mg Tablet

The provided text is "undefined," therefore no rephrasing is possible.

Uses of Sugwin-VG 2mg/500mg/0.2mg Tablet

Managing type 2 diabetes

Major Benefits of Sugwin-VG 2mg/500mg/0.2mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Sugwin-VG 2mg/500mg/0.2mg Tablet on an empty stomach.

Common Side effects of Sugwin-VG 2mg/500mg/0.2mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Sugwin-VG 2mg/500mg/0.2mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Sugwin-VG 2mg/500mg/0.2mg Tablet on an empty stomach.

How Sugwin-VG 2mg/500mg/0.2mg Tablet works:

Each Sugwin-VG tablet (2mg/500mg/0.2mg) combines three agents to manage blood sugar.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Sugwin-VG 2mg/500mg/0.2mg tablets with alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sugwin-VG 2mg/500mg/0.2mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescription. Seek medical advice before taking this medication.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sugwin-VG 2mg/500mg/0.2mg tablets while breastfeeding is likely inadvisable. Preliminary human studies indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

The use of Sugwin-VG 2mg/500mg/0.2mg tablets is inadvisable for individuals with kidney impairment and should be diligently avoided. Patients with severe kidney disease should especially refrain from using this medication; physician consultation is strongly recommended.

LiverLiverCAUTION

Patients with liver impairment should use Sugwin-VG 2mg/500mg/0.2mg tablets cautiously, potentially requiring dosage modification. Consult a physician. For those with mild to moderate liver disease, initiation should be at a low dose; the medication is contraindicated in cases of severe hepatic dysfunction.

What if you forget to take Sugwin-VG 2mg/500mg/0.2mg Tablet :

Should you forget to take your Sugwin-VG 2mg/500mg/0.2mg Tablet, administer it immediately upon remembering. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Sugwin-VG 2mg/500mg/0.2mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Sugwin-VG 2mg/500mg/0.2mg Tablet

Sugwin-VG 2mg/500mg/0.2mg tablets combine glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus in adults. This treatment improves blood glucose control when combined with diet and exercise. Glimepiride stimulates insulin release from the pancreas; metformin reduces liver glucose production and enhances insulin sensitivity; and voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose levels. This combination is unsuitable for type 1 diabetes.
Sugwin-VG 2mg/500mg/0.2mg Tablets may cause common side effects including hypoglycemia, nausea, diarrhea, altered taste perception, flatulence, abdominal pain, headache, rash, and respiratory infections.
Patients with known allergies to Sugwin-VG 2mg/500mg/0.2mg Tablet components or excipients, moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis (including diabetic ketoacidosis) should not use this medication.
Combining Sugwin-VG 2mg/500mg/0.2mg Tablet with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Sugwin-VG 2mg/500mg/0.2mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with skipped meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication. Keep it out of reach of children, pets, and others.
Sugwin-VG 2mg/500mg/0.2mg...
86
MRP 105
18% off